Overview

Headquartered in Calgary, Alberta, Canada we hope to enable broad access to the technology of ultrasensitive diagnostics tools for resource-limited settings across the globe. We are currently working on a cartridge-based COVID-19 test to provide much needed rapid and accurate diagnostics in the fight against the globals COVID-19 pandemic. Illucidx continues to perfect our ultra-sensitive near-patient malaria diagnostics designed for deployment in malaria-endemic resource-limited countries.